DCF — FRANCISCAN HEALTH- DYER
Enterprise Value: $-256.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-256.9M
Enterprise Value
$-81.9M
PV of Cash Flows
$-175.1M
PV of Terminal Value
$-281.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $177.9M | $-15.7M | -9.0% | $-23.2M | $-21.1M |
| Year 2 | $183.2M | $-14.3M | -8.0% | $-22.1M | $-18.3M |
| Year 3 | $188.7M | $-12.9M | -7.0% | $-20.9M | $-15.7M |
| Year 4 | $194.4M | $-12.3M | -6.0% | $-20.5M | $-14.0M |
| Year 5 | $200.2M | $-12.2M | -6.0% | $-20.6M | $-12.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-256.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$172.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09321496686406179
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5